The stability mechanisms of an injectable calcium phosphate ceramic suspension.
Calcium phosphate ceramics are widely used as bone substitutes in dentistry and orthopedic applications. For minimally invasive surgery an injectable calcium phosphate ceramic suspension (ICPCS) was developed. It consists in a biopolymer (hydroxypropylmethylcellulose: HPMC) as matrix and bioactive calcium phosphate ceramics (biphasic calcium phosphate: BCP) as fillers. The stability of the suspension is essential to this generation of "ready to use" injectable biomaterial. But, during storage, the particles settle down. The engineering sciences have long been interested in models describing the settling (or sedimentation) of particles in viscous fluids. Our work is dedicated to the comprehension of the effect of the formulation on the stability of calcium phosphate suspension before and after steam sterilization. The rheological characterization revealed the macromolecular behavior of the suspending medium. The investigations of settling kinetics showed the influence of the BCP particle size and the HPMC concentration on the settling velocity and sediment compactness before and after sterilization. To decrease the sedimentation process, the granule size has to be smaller and the polymer concentration has to increase. A much lower sedimentation velocity, as compared to Stokes law, is observed and interpreted in terms of interactions between the polymer network in solution and the particles. This experimentation highlights the granules spacer property of hydrophilic macromolecules that is a key issue for interconnection control, one of the better ways to improve osteoconduction and bioactivity.
Fatimi
Ahmed
A
Laboratoire d'Ingénierie Ostéo-Articulaire et Dentaire (LIOAD), INSERM U791, 1 Place Alexis Ricordeau, BP 84215, 44042 Nantes Cedex 1, France.
Tassin
Jean-François
JF
Axelos
Monique A V
MA
Weiss
Pierre
P
D001672:Biocompatible Materials / Q000494:pharmacology; D018786:Bone Substitutes / Q000494:pharmacology; D002130:Calcium Phosphates / Q000494:pharmacology*; D002516:Ceramics / Q000494:pharmacology; D065347:Hypromellose Derivatives; D007267:Injections; D008747:Methylcellulose / Q000031:analogs & derivatives; D010316:Particle Size; D011108:Polymers / Q000494:pharmacology; D012212:Rheology; D014783:Viscosity
D001672:Biocompatible Materials; D018786:Bone Substitutes; D002130:Calcium Phosphates; D011108:Polymers; D065347:Hypromellose Derivatives; D008747:Methylcellulose; C020243:calcium phosphate